What is Kura Oncology's investment proceeds?

Kura Oncology (KURA) reported investment proceeds of $147.5M in Q1 2026.

How has Kura Oncology's investment proceeds changed year-over-year?

Kura Oncology's investment proceeds decreased by 12.0% year-over-year, from $167.6M to $147.5M.

What is the long-term trend for Kura Oncology's investment proceeds?

Over 3 years (2022 to 2025), Kura Oncology's investment proceeds has grown at a 35.4% compound annual growth rate (CAGR), from $303.91M to $755.13M.

What does investment proceeds mean?

Cash received from sales, maturities, and redemptions of investment securities across all categories.

Kura Oncology KURA Investment Proceeds

Investment Proceeds at other companies

Syndax PharmaceuticalsSNDX

$77.78M-25.7%

Corvus PharmaceuticalsCRVS

$16.98M+41.7%

IncyteINCY

$0-100%

Bicara TherapeuticsBCAX

$101M—

Ethos Technologies, Inc. LIFE

$17.5M-6.3%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's investment proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's investment proceeds?: Kura Oncology (KURA) reported investment proceeds of $147.5M in Q1 2026.
How has Kura Oncology's investment proceeds changed year-over-year?: Kura Oncology's investment proceeds decreased by 12.0% year-over-year, from $167.6M to $147.5M.
What is the long-term trend for Kura Oncology's investment proceeds?: Over 3 years (2022 to 2025), Kura Oncology's investment proceeds has grown at a 35.4% compound annual growth rate (CAGR), from $303.91M to $755.13M.
What does investment proceeds mean?: Cash received from sales, maturities, and redemptions of investment securities across all categories.